The global clinical nutrition market size was valued at USD 34,825 million in 2021. It is projected to reach USD 60,350 million by 2030, growing at a CAGR of 6.3% during the forecast period (2022–2030). North America is the largest region and is estimated to grow at a CAGR of 5.5% during the forecast period.
/EIN News/ — New York, United States, July 21, 2022 (GLOBE NEWSWIRE) — A clinical nutrition product improves a patient’s health. Necessary supplements such as minerals, vitamins, and other nutrients aid in the improvement of the metabolic system. Clinical nutrition diagnoses and treats disorders that influence dietary intake, intestinal absorption, and metabolism and promote health through diet-related disease prevention.
There is a rise in the demand for clinical nutrition owing to an increase in chronic and lifestyle-related diseases such as inflammatory bowel disease and diabetes mellitus. The increase in the geriatric population also contributes to market growth. Additionally, the increase in R&D investments made by the Government in the healthcare sector drives the development of the clinical nutrition market.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/clinical-nutrition-market/request-sample
Growing Incidences of Chronic and Lifestyle-Associated Diseases Spurs the Global Clinical Nutrition Market
The growing prevalence of chronic and life-associated diseases drives the growth of the clinical nutrition market. According to the WHO, 60% of related factors to individual health and quality of life are correlated to lifestyle, and millions of people follow an unhealthy lifestyle. Problems like metabolic diseases, joint and skeletal issues, cardiovascular diseases, hypertension, overweight, and violence can be caused by an unhealthy lifestyle. Several other disorders require clinical nutrition care, such as anorexia, cachexia, food allergy, and intolerance of disaccharides. Individuals suffering from these syndromes often have nutritional deficiency problems. In recent years, a significant rise in the incidence rate of nutritional problems has been witnessed across the globe. For example, according to the American Society of Parenteral and Enteral Nutrition, around 150,000 infants and hospitalized patients receive nutrition support annually in the US.
Furthermore, chronic gastrointestinal (GI) diseases such as peptic ulcers, food allergy, constipation, diverticulosis, inflammatory bowel disease, and colon cancer commonly result in malnutrition and morbidity. This will boost the market for clinical nutrition. According to the WHO, four of every ten adults worldwide suffer from functional gastrointestinal disorders of varying severity. A rise in the number of nutrition-related diseases globally is anticipated to drive the market for clinical nutrition in the near future.
|Market Size||USD 60.35 Billion by 2030|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Service Type, Vehicle Type, Regions|
|Geographies Covered||North America, Europe, Asia-Pacific, LAME and Rest of the World|
|Key Companies Profiled/Vendors||Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc, Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc, Lonza Ltd, Nestlé S.A, Hero Nutritionals Inc|
|Key Market Opportunities||Underlying Growth Opportunities in Emerging Economies|
|Key Market Drivers||Rising Incidences of Chronic and Lifestyle-Associated Disease
Growing Geriatric Population
Buy Now Full Report @ https://straitsresearch.com/buy-now/clinical-nutrition-market
Underlying Growth Opportunities in Emerging Economies for the Global Clinical Nutrition Market
The emerging economies of the Asia-Pacific and LAMEA regions offer lucrative growth opportunities for the clinical nutrition market due to improved healthcare infrastructure and increased demand for better healthcare. In addition, the rise in the incidence of various lifestyle and chronic diseases that develop a problem of malnutrition and dietary issues and increase in the research required for the development of medical devices for clinical nutrition of various illnesses such as respiratory, renal and cancer, have boosted the demand for the clinical nutrition market.
Furthermore, an increase in the geriatric population with a lack of nutrition creates new opportunities for the growth of the clinical nutrition market. According to the Global Data article, in 2020, Asia-Pacific accounted for the maximum number of older adults, around 226 million. Additionally, the surge in healthcare reforms in developing nations is anticipated to offer remunerative opportunities for market expansion. An increase in healthcare and R&D investments in India, China, and Brazil also spur market growth.
North America is the largest region and is estimated to grow at a CAGR of 5.5% during the forecast period. Continuous R&D toward creating new clinical nutrition is a prominent trend in the North American clinical nutrition industry. In addition, for various chronic conditions such as coronary artery disease, ischemic stroke, diabetes, and a few cancer indications. The incidence of diabetes has increased the demand for medical nutrition therapy. Moreover, increasing demand for clinical nutrition in the pediatric category is expected to offer lucrative growth opportunities for players in the market.
Asia-Pacific is the fastest-growing region. The major factors attributing to the growth of the Asia Pacific clinical nutrition market include an increase in the prevalence of metabolic disorders and neurological diseases, a rise in the geriatric population in the Asia Pacific Region, and high spending on healthcare.
Europe is the second-largest region and is projected to reach USD 17,325 million by 2030, growing at a CAGR of 6.2%. The alarming increase in nutrition therapy and dietary therapy for patients diagnosed with metabolic syndrome is a significant driver of the clinical nutrition market in this region. In addition, a rise in awareness among patients in European countries regarding the availability of clinical nutrition is anticipated to boost the market growth.
- The global clinical nutrition market was valued at USD 34,825 million in 2021. It is projected to reach USD 60,350 million by 2030, growing at a CAGR of 6.3% during the forecast period (2022–2030).
- Based on route of administration, the global clinical nutrition market is classified into Oral, Enteral, and Parenteral. The Oral route of administration holds the highest market share and is estimated to grow at a CAGR of 5.7% during the forecast period.
- Based on application, the global clinical nutrition market is categorized into Cancer, Neurological Diseases, Gastrointestinal Disorders, and Others. The Gastrointestinal Disorders segment is the highest contributor to the market and is estimated to grow at a CAGR of 5.6% during the forecast period.
- Based on end-user, the global clinical nutrition market is segmented into Pediatric, Adults, and Geriatric. The Pediatric segment is the largest shareholder and is estimated to grow at a CAGR of 7% during the forecast period.
- Based on regions, the global clinical nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America holds the leading position in the market and is estimated to grow at a CAGR of 5.5% during the forecast period.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/clinical-nutrition-market/request-sample
Key players in the clinical nutrition market are
- Abbott Laboratories
- B. Braun Melsungen AG
- Danone Nutricia
- Baxter International Inc.
- Fresenius SE & Co. KGaA
- Perrigo Company Plc
- Pfizer Inc.
- Lonza Ltd
- Nestlé S.A.
- Hero Nutritionals Inc.
Global Clinical Nutrition Market: Segmentation
By Route of Administration
- Neurological Diseases
- Gastrointestinal Disorders
- Metabolic Disorders
- North America
TABLE OF CONTENT
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Clinical Nutrition Market
3.3 Key Market Trends
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 Type Overview
4.1.1 Market Size & Forecast (Value)
4.2 Infant Formula
4.2.1 Market Size & Forecast (Value)
4.3.1 Market Size & Forecast (Value)
4.4.1 Market Size & Forecast (Value)
5 End User Overview
5.1.1 Market Size & Forecast (Value)
5.2.1 Market Size & Forecast (Value)
5.3.1 Market Size & Forecast (Value)
5.4.1 Market Size & Forecast (Value)
5.5.1 Market Size & Forecast (Value)
6 Regional Overview
6.1.1 Market Size & Forecast (Value)
6.2.1 North America
188.8.131.52.1 By Type
184.108.40.206.2 By End User
220.127.116.11.1 By Type
18.104.22.168.2 By End User
22.214.171.124.1 By Type
126.96.36.199.2 By End User
6.2.2 Latin America
188.8.131.52 By Type
184.108.40.206 By End User
220.127.116.11.1.1 By Type
18.104.22.168.1.2 By End User
22.214.171.124.2.1 By Type
126.96.36.199.2.2 By End User
188.8.131.52.3 Rest of South America
184.108.40.206.3.1 By Type
220.127.116.11.3.2 By End User
6.3.1 Market Size & Forecast (Value)
6.3.2 Western Europe
18.104.22.168.1 By Type
22.214.171.124.2 By End User
126.96.36.199.1 By Type
188.8.131.52.2 By End User
184.108.40.206.1 By Type
220.127.116.11.2 By End User
18.104.22.168.1 By Type
22.214.171.124.2 By End User
126.96.36.199.1 By Type
188.8.131.52.2 By End User
184.108.40.206 Rest of Western Europe
220.127.116.11.1 By Type
18.104.22.168.2 By End User
6.3.3 Eastern Europe
22.214.171.124 By Type
126.96.36.199 By End User
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
188.8.131.52 By Type
184.108.40.206 By End User
220.127.116.11 By Type
18.104.22.168 By End User
22.214.171.124 By Type
126.96.36.199 By End User
188.8.131.52 By Type
184.108.40.206 By End User
6.4.6 South Korea
220.127.116.11 By Type
18.104.22.168 By End User
6.4.7 Rest of Asia-Pacific
22.214.171.124 By Type
126.96.36.199 By End User
6.5 Middle East & Africa
6.5.1 The Middle East
188.8.131.52 Market Size & Forecast (Value)
184.108.40.206 Saudi Arabia
220.127.116.11.1 By Type
18.104.22.168.2 By End User
22.214.171.124.1 By Type
126.96.36.199.2 By End User
188.8.131.52.1 By Type
184.108.40.206.2 By End User
6.5.2 The Africa
220.127.116.11 Market Size & Forecast (Value)
7 Company Profile
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 Fresenius Kabi
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Reckitt Benckiser
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 B Braun. Collaborations
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
Table of Content and Figure @ https://straitsresearch.com/report/clinical-nutrition-market/toc
- In May 2022, Abbott announced that the United States District Court for the Western District of Michigan had amended the recent consent decree, allowing Abbott to release limited quantities of its EleCare® specialty amino acid-based formulas that were previously on hold following the recall of some powder infant formulas from its Sturgis, Mich., facility on February 17th. Abbott and the U.S. Food and Drug Administration (FDA) requested that the consent decree be altered to allow the business to get EleCare to children in urgent medical need. According to an agreement with the FDA, several EleCare product batches were put on hold.
Have a Look at the Related Research Report
Specialized Formula Medical Nutrition Market: Information by Type (Infant Medical Nutrition Products), Application (Pediatric/Infants, Geriatric), and Region — Forecast till 2029
Personalized Medicine Market: Information by Product (Personalized Nutrition & Wellness), Application (Disease Treatment) and Region — Forecast till 2029
MMA Equipment, Merchandise, and Nutrition Market: Information by Product (Equipment, Nutrition, and Merchandise) and Region — Forecast till 2029
Mixed Martial Arts Equipment Market: Information by Equipment (Gloves, Guards, Punching Bags, Hand Wraps, Others), Nutritional Supplement, and Region — Forecast till 2026
Dairy Protein Market: Information by Type (Whey Protein, Milk Protein Concentrate), Application (Food and Beverages, Nutrition), Form (Solid, Liquid), and Region – Forecast till 2030
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: [email protected]